Haresabadi Mahdi, Esfahani Ensieh Nasli, Mansournia Mohammad Ali, Namazi Nazli, Pourmostadam Bijan, Ostovar Afshin, Fotouhi Akbar
Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
BMC Public Health. 2025 Aug 6;25(1):2667. doi: 10.1186/s12889-025-23955-y.
Diabetic Retinopathy (DR) is a microvascular complication of diabetes mellitus. Health policymakers are interested in studying the impact of interventions on reducing new cases of DR. The study aimed to calculate the generalized impact fraction (GIF) and population attributable fraction (PAF) of interventions targeting three risk factors on the five-year risk of DR.
A retrospective cohort study was conducted among 1,742 patients with diabetes who completed their baseline assessment between 2015 and 2017. Follow-up studies were carried out during visits from 2020 to 2022, aiming to determine the five-year risk of DR. To estimate the PAF and GIF in different scenarios, a parametric G. formula was utilized.
In this study, all patients had type 2 diabetes, and the five-year risk of developing diabetic retinopathy (DR) was 16.1% (95% CI: 14.4-18.0). Lowering HbA1c to below 7% would be expected to prevent 35.07% (95% CI: 34.7-36.2) of DR cases. A reduction of 30% in patients with HbA1c levels above 7% corresponds to a GIF of 10.3% (95% CI: 9.9-10.7). Similarly, normalizing blood pressure levels resulted in a PAF of 22.1% (95% CI: 21.8-22.6). A 25% decrease in prevalence above 130/80 mmHg was associated with a GIF for DR of 5.3% (95% CI: 5.1-5.4). Reducing LDL cholesterol levels to less than 100 mg/dl had a lower impact, with a PAF of 1.9% (95% CI: 1.3-2.3). A 20% reduction in prevalence above this level corresponded to a GIF of 0.3% (95% CI: 0.2-0.5).
Reducing HbA1c and blood pressure by 20-30% would be expected to prevent the five-year risk of DR by 15.5% (95% CI: 15.3-15.9). These levels of decrease are achievable and conceivable to policymakers, which can encourage them to implement a program. This could be a Policy-making approach to prevent DR.
糖尿病视网膜病变(DR)是糖尿病的一种微血管并发症。卫生政策制定者有兴趣研究干预措施对减少DR新发病例的影响。该研究旨在计算针对三个风险因素的干预措施对DR五年风险的广义影响分数(GIF)和人群归因分数(PAF)。
对1742例在2015年至2017年期间完成基线评估的糖尿病患者进行了一项回顾性队列研究。在2020年至2022年的随访期间进行了后续研究,旨在确定DR的五年风险。为了估计不同情况下的PAF和GIF,使用了参数G.公式。
在本研究中,所有患者均为2型糖尿病,发生糖尿病视网膜病变(DR)的五年风险为16.1%(95%CI:14.4-18.0)。将糖化血红蛋白(HbA1c)降至7%以下预计可预防35.07%(95%CI:34.7-36.2)的DR病例。HbA1c水平高于7%的患者降低30%对应GIF为10.3%(95%CI:9.9-10.7)。同样,使血压水平正常化导致PAF为22.1%(95%CI:21.8-22.6)。收缩压/舒张压高于130/80 mmHg的患病率降低25%与DR的GIF为5.3%(95%CI:5.1-5.4)相关。将低密度脂蛋白胆固醇(LDL)水平降至低于100mg/dl的影响较小,PAF为1.9%(95%CI:1.3-2.3)。高于此水平的患病率降低20%对应GIF为0.3%(95%CI:0.2-0.5)。
将HbA1c和血压降低20%-30%预计可将DR的五年风险降低15.5%(95%CI:15.3-15.9)。政策制定者可以实现并设想这些降低水平,这可以鼓励他们实施一项计划。这可能是一种预防DR的政策制定方法。